Living & Coping with Type 2 Diabetes: Blood Glucose Monitoring, Medication Adherence, Balanced Nutrition, Foot & Eye Care, and Emotional Well-Being
A chronic care guide on home glucose monitoring and continuous monitors, medication adherence, A1C milestone tracking, the plate method, activity, daily foot checks and annual eye examinations, diabetes distress and building a care team.
Submitted research brief - Submitted to OwieClear; written with an AI assistant - November 2026
Read this first. This document was written outside OwieClear and has not been reviewed by a clinician. We publish it so you can read the source for yourself. It is educational and is not medical advice. Where our own pages disagree with it, follow our pages, which cite their sources, and ask a healthcare professional about anything that affects your care.
What we found that needs correcting
- This guide gets the daily architecture right, and two of its choices are better than most: naming diabetes distress and burnout explicitly, and putting daily foot inspection and annual dilated eye examinations in the core routine rather than in a footnote. The notes below fill the safety gaps.
- The largest omission is low blood sugar. The guide covers monitoring and medication adherence without mentioning hypoglycemia at all, and this is the main safety issue in diabetes treatment. Insulin and sulfonylureas can cause it; metformin, GLP-1 agonists, SGLT2 inhibitors and DPP-4 inhibitors do not cause it on their own. Anyone on the first group needs the warning signs, the rule of 15 (15 grams of fast-acting carbohydrate, wait 15 minutes, recheck), and the instruction never to put food or drink into the mouth of someone who cannot swallow safely. Those at risk of severe episodes should have glucagon prescribed and the people around them shown how to use it.
- Sick-day rules are missing and are needed before illness arrives, not during it. Blood sugar usually rises with infection even when appetite is gone, so diabetes medicines are generally continued. Some are held during significant illness, dehydration, vomiting or prolonged fasting, particularly SGLT2 inhibitors and metformin, and people should ask which of theirs are on that list and write it down.
- SGLT2 inhibitors carry one specific hazard worth stating: ketoacidosis can occur with near-normal blood sugar. Feeling very unwell with nausea, vomiting or deep rapid breathing deserves assessment even when the meter reads normally, and a normal reading should not be reassuring in that situation.
- The monitoring section advises checking as your physician directs, which is sound, but it leaves out the finding people most need. Routine daily finger-stick testing has not been shown to improve A1C meaningfully in people taking metformin alone or other medicines that do not cause lows. Structured checking for a defined question, such as paired readings before and two hours after a meal, is far more useful than daily habit, and it removes a daily source of guilt that achieves nothing.
- Target numbers would make the section actionable: commonly 80 to 130 mg/dL before meals and under 180 mg/dL two hours after, with targets deliberately loosened for older adults and anyone with a history of severe lows. For continuous monitors, time in range above 70 percent, with time below 70 mg/dL under 4 percent.
- Hand washing before a finger-stick check deserves a line. Fruit, juice or lotion on a finger produces dramatically false high readings, and a large share of alarming results are this artefact.
- The annual review list should include the urine albumin-to-creatinine ratio by name. It detects kidney involvement years before blood tests change and is one of the most commonly omitted tests in diabetes care. Blood pressure and a lipid panel belong there too, since both reduce complications at least as much as glucose control does.
- Medication adherence is covered well, but the companion point is missing: do not stop diabetes medicines because readings have improved, since the improvement is usually because of them. After substantial weight loss, insulin and sulfonylurea doses often do need reducing, and that is planned with a clinician rather than improvised.
- Cost is the most common unspoken reason treatment plans fail, and the guide does not mention it. Metformin and sulfonylureas are inexpensive and effective where newer agents are unaffordable, assistance programs and 90-day supplies exist, and insulin should never be rationed silently. People rarely raise this unless asked, and a plan built on wrong information gets escalated instead of fixed.
- Depression deserves a line alongside diabetes distress. It occurs roughly twice as often in people with diabetes and is strongly linked with worse control, and it is treated differently from distress.
- Everything else in the guide is accurate: glucose tracking by meter or CGM with a log of patterns; taking oral and injectable therapies exactly as prescribed with reminders; A1C every 3 to 6 months against an individualized target; the plate method with half non-starchy vegetables, a quarter lean protein and a quarter high-fibre carbohydrate; limiting sugary drinks and processed snacks; aerobic and strength work improving glucose uptake by muscle; daily foot inspection, properly fitting shoes and annual dilated eye examinations; diabetes distress and burnout as common and not a character failure; and a team including a CDCES and a registered dietitian alongside peer support.
Download the PDF
Our reviewed pages on this
All source documents